Clinical Trials · NCT04877431
A Study of Teduglutide (Revestive®) in Children, Teenagers and Adults With Short Bowel Disease
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Takeda
- Enrollment
- 45
- Start date
- Nov 2020
- Locations
- 1 site, Argentina
- Primary endpoint
- Number of Participants With Adverse Events of Special Interest (AESI)